Quantzig, global data analytics and advisory firm, that delivers actionable analytics solutions presents a new case study series that focuses on how coronavirus is impacting businesses across geographies.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200428005905/en/
Outmaneuver uncertainty with detailed data-driven insights backed with smart analytics platforms. Request a FREE proposal to gain comprehensive solution insights.
The transformation of the COVID-19 outbreak into a pandemic has brought about significant shifts in business processes and market needs. The pandemic is provoking severe budgetary strains in many segments of the economy, due to which companies are forced to scale down operations to balance the financial impact of the crisis. In this case, the client wanted to analyze drug safety data obtained from various sources to build synergy between traditional analytics and clinical data to provide faster and better insights across the organization.
How Quantzig’s COVID-19 business support solutions can help pharma companies?
- Our specially curated analytics solutions focus on ensuring business continuity to help businesses navigate the crisis
- We also offer access to a library of best practices and analytics methodologies that can help businesses carry out operations smoothly by identifying the COVID-19 impact areas
- Our services involve combinations of components like portal access, ad-hoc/steady projects, and consulting services
Navigating the crisis is no big deal, provided you possess the organizational readiness to shift and adapt to a different environment. Talk to our analytics experts to learn how we can help you adapt and thrive in the new normal.
Pharmacovigilance Analytics Engagement Overview:
The current global scenario in which businesses are struggling to stay afloat is truly unprecedented. The global supply chain has been disrupted, lockdowns have been enforced, and businesses have been pushed to adapt and thrive in the new reality. The client wanted to analyze drug safety data obtained from various sources to build synergy between traditional analytics and clinical data to provide faster and better insights across the organization.
Quantzig’s pharmacovigilance analytics solutions helped the client to:
- Reduce preparation time for drug safety reviews from days to hours
- Understand safety risks earlier in the drug development phase
- Maintain good relationships with regulators
- Enhance the protection of patients through
According to Quantzig’s pharmacovigilance analytics experts, “Greater emphasis on drug safety is one of the key drivers of the growing demand for pharmacovigilance solutions globally.”
Transform your business with impactful insights and innovative technologies. Request a FREE demo to learn more.
Quantzig’s Healthcare Provider Analytics Value Proposition
Our industry-leading solutions combine cutting-edge analytics methodologies, advanced algorithms, and data science with intuitive, interactive dashboards that help drive shareholder value and business outcomes. Quantzig’s advanced analytics platforms also ensure complete visibility into business and supply chain operations, empowering businesses to enhance efficiency. By adopting our solutions organizations can realize the benefits of lower operating costs obtained by optimizing fulfillment, customer experience, and improvements in overall business performance. What sets us apart amid the competition is that our proprietary algorithms and advanced analytics platforms are designed to support the unique needs of our clients from different industries, thereby ensuring we deliver maximum value and returns to our clients.
Quantzig’s healthcare provider analytics capabilities include:
1: Clinical Trial Reporting and Analytics
2: Drug Pricing and Promotion Analytics
3: Patient Data Analytics
Based on our analysis, the impact of the ongoing crisis will have a prolonged effect on key business processes, and companies will have to deploy advanced analytics models that leverage machine learning algorithms to ingest large disaggregated data sets and identify data patterns.
We predict that 2020 will bring in a host of new challenges for the pharma industry in the form of:
- Data complexities
- Rise in competition
- Stringent regulations
With over 15+ years of experience in offering advanced marketing analytics solutions, our analytics experts have developed a comprehensive solutions portfolio that can help you extract more value from your investments by leveraging analytics at strategic points in the value chain. Request more information to learn more about our capabilities and analytics offerings.
Latest COVID-19 Insights: FREE Downloads
- Managing Delinquency Amid a Crisis: Quantzig’s Take on How Financial Data Analytics Can Help
- COVID-19: A Black Swan Event for the US Oil and Gas Industry?
- How Ventilator Manufacturers are Dealing with Material Shortages Amidst COVID-19 Crisis: 3 Lessons
Explore our COVID-19 resource library for detailed analyst insights: https://bit.ly/2xcQsfI
About Quantzig
Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across the globe with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit: https://www.quantzig.com/request-for-proposal
View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005905/en/
Contacts
Quantzig
Anirban Choudhury
Marketing Manager
US: +1 630 538 7144
UK: +44 208 629 1455
https://www.quantzig.com/contact-us
Source: Quantzig
View this news release online at:
http://www.businesswire.com/news/home/20200428005905/en
